PER 2.35% 8.3¢ percheron therapeutics limited

Ann: ANP and MCRI new R&D collaboration for ATL1102, page-50

  1. 3,547 Posts.
    lightbulb Created with Sketch. 771
    Yes everyone is thinking that a CR is on the way..want happened to non dilutive funding that has been mentioned a few times?

    Again the last announcement on partnership with Murdoch suggests that they are funding some trials with existing funds. Grant being applied to conduct further tests and trials..Now with just around 7-8m in the bank we would think that CR is on the way. Million $$ question is at what price??

    Also my views is around $27m needed for EMA and with USA being possibly done at the same time that is another $50m..

    So looking at $75m plus some extra money for general spending..

    I don't think they would be raising that sort of money by CR..Hence very interesting times ahead to see where the finance is going to come from..part CR part Partnership ..or one big partner financing the whole EMA and USA with % of market as a deal...

    Yes..they need to pull everything out of the hat to get this moving...any CR at these levels is a joke ...higher prices at around 40c would be great....

    Let see what our MD has got for us...should be out in the next few weeks...As I have said before he has taken the finance part too easy..may be he is organised...

    Let's c..
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.3¢
Change
-0.002(2.35%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $2.895K 34.82K

Buyers (Bids)

No. Vol. Price($)
1 30000 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 120177 1
View Market Depth
Last trade - 12.51pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.